Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition
- 26 January 2006
- journal article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 106 (3), 367-372
- https://doi.org/10.1016/j.ijcard.2005.02.016
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Review of aldosterone- and angiotensin II-induced target organ damage and preventionCardiovascular Research, 2004
- The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTPublished by Oxford University Press (OUP) ,2004
- Chronic beta-blocker treatment in patients with advanced heart failure: Effects on neurohormonesInternational Journal of Cardiology, 2000
- Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failureEuropean Heart Journal, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.Heart, 1996
- Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunctionThe American Journal of Cardiology, 1995
- Determinants of angiotensin II generation during converting enzyme inhibition.Hypertension, 1990
- Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.Hypertension, 1990
- Increase in plasma aldosterone during prolonged captopril treatmentThe American Journal of Cardiology, 1982